SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E
http://www.w3.org/2000/01/rdf-schema#comment
"These findings indicate that an aberrant Wnt/beta-catenin signalling leads to the epithelial-mesenchymal transition and drug resistance of glioma via Fra1 induction which suggests novel therapeutic strategies for the malignant disease."
xsd:string
http://purl.uniprot.org/uniprot/#_4B7B80104DB5E2240BCB39FF155D7D51995CB2C357E80B31B9D1F532CB874B2745CF5164C40FB5565392890C3F412FE8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E
http://purl.uniprot.org/uniprot/E9PKL5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E
http://purl.uniprot.org/uniprot/#_E9PKL5-mappedCitation-28232512
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F6C18AB30BE1F8C16258BF13B46E87751BAC2F4403639CA14FABA6DB692E398AF08AF89ECDF3CFC5309B83460E96987E